Body Composition Analyzers Market By Product (Bio-Impedance Analyzers, Dual-Energy X-Ray Absorptiometry (DEXA), Skinfold Calipers, Air Displacement Plethysmography(ADP), Hydrostatic Weighing) By End Users (Hospitals, Fitness Centers, Academic & Research Centers, Home Users) - Growth, Future Prospects & Competitive Analysis, 2016 – 2028

The global body composition analyzers market report explores the critical analysis of the body composition analyzers industry using key parameters. The report consists of investment strategies, the need for investments in the body composition analyzers industry, and the multiple benefits for the investors. Importantly, this report sets out major changes in the global technical regulations for the body composition analyzers industry and how economic and non-economic barriers are helping the body composition analyzers market grow. Moreover, the report analyzes the global, regional, and country-level historic and forecasted market size. The report also provides a comprehensive analysis of key investment propositions, demand and supply gap, competitors positioning, STAR analysis, SRC analysis, and Tornado analysis. Key technological developments and other analyses such as porter's five forces analysis, PESTEL analysis, value chain analysis, etc.

Key Highlights of the report

How are the major segments performing in the Body Composition Analyzers market?

In 2021, the bio-impedance analyzers segment held a prominent share due to the advantages of these products over different body composition analyzers, such as effortless operations, lower cost, and adequate accuracy.

In 2021, the fitness center was augmented to hold a significant share in the market as the number of fitness clubs has grown significantly due to the growing emphasis on health and fitness among people.

Which region dominated the body composition analyzers market?

In 2021, North America dominated the body composition analyzers market regarding market share and revenue and will resume growing its supremacy during the forecast period. This is because of the growing prevalence of lifestyle disorders. On the other hand, Asia-Pacific is projected to show the highest development rate during the forecast period. Furthermore, owing to the rising research and development proficiencies, the growing rate of obesity, unhealthy dietary patterns and the ever-rising geriatric population.

What is the competitive environment of the body composition analyzers market?

The body composition analysis industry's competitive environment offers information on the total economic profit made by suppliers and businesses, the sales and revenues produced in this sector, the body composition analyzers market share globally, the business organization overview, the launch of new products, and the opportunities for the industrial body composition analyzers market. For instance, in April 2022, InBody, an enterprise specializing in body composition technology, launched the BWA 2.0 body water analyzer, which delivers data on how body composition and body water impact wellbeing. This new professional-grade machine grows on the InBody S10's outputs, which operate attachable electrodes to analyze body composition and water in immobile users or who have amputated limbs. Furthermore, in January 2022, Withings unveiled Body Scan, which calculates nerve activity through sweat, body composition, and more. Following up behind its latest smartwatch established at the end of 2021, Withings revealed its next major smart health device in 2022. Body Scan will deliver advanced body composition readings, nerve activity via sweat, 6-lead ECGs, vascular health, personalized health plans, clinical support, and more.

Executive Summary

What was the impact of the COVID-19 pandemic on the body composition analyzers market?

The COVID-19 pandemic is an unprecedented global public health challenge and is expected to harm the Body Composition Analyzers market. Due to lockdowns and stay-at-home directives. Furthermore, people have much more time than earlier. Numerous people drink carbo-hydrated beverages and eat nonhealthy fat due to lifestyle modifications and the comfort of home-delivered food. These elements underestimate the demand for body composition analyzers for observing health during lockdowns. Thus COVID-19 pandemic hinders market growth.

Which are the key investments by the players in the body composition analyzers industry market?

Various players are creating new products that particularly contribute to market growth. For instance, in January 2020, Inbody USA officially established the InBody 970 at CES Las Vegas. The InBody 970, paired with the Yscope, utilizes unique patented technology to investigate and classify abdominal fat and total body water. Also, in January 2022, Withings established an even smarter scale to estimate from top to toe. The latest Body Scan adds elements to the otherwise familiar-looking scale from Withings. Thus, the overhead factors are projected to contribute to the market growth over the forecast period.

Some of the major players in the market are Omron Corporation, InBody Co., Ltd, Hologic, Inc., GE Healthcare, Bodystat Ltd, COSMED S.r.L, RJL Systems, SELVAS AI Inc., Tanita Corporation, Fitbit Inc., Koninklijke Philips NV, Withings, EatSmart Inc., Yunmai Smart Scale, and Charder Electronic Co. Ltd.

What are the Major Driving Factors for the Body Composition Analyzers Market?

The rising prevalence of lifestyle disorders increased focus on research and development proficiencies in medical devices, and the adoption of advanced healthcare technologies are major factors driving the market. Furthermore, the growing rate of obesity and rising expenditure for the development of healthcare infrastructure, especially in growing economies, are the major factors that enhance the growth of the body composition analyzers market. Moreover, an upsurge in adopting unhealthy dietary patterns is one of the major factors fostering market growth. A surging geriatric population base coupled with growing technological innovations and advancements is another market growth determinant. Rising health awareness among individuals, growing prevalence of metabolic disorders and rising medical tourism are other important factors that will further generate lucrative market growth.

What are the Major Risks for the Body Composition Analyzers Market?

The high equipment cost is likely to hamper the market's growth. Body composition analyzers are provided with advanced components and functionalities and are priced at a premium. The price of an instrument is established on its applications. Furthermore, it is challenging for academic research laboratories to afford these systems as they have restricted budgets. The price of air displacement plethysmography equipment varies from USD 30,000–40,000, which is extremely expensive even for health clubs. Moreover, the price of dual-energy X-ray absorptiometry is also high. Thus, increased equipment cost is likely to hinder market growth.

Which is the key end-user in the body composition analyzers market?

The hospital segment is expected to maintain a prominent market share in the global body composition analyzers during the forecast period. In hospitals, body composition analysis is majorly utilized to diagnose osteoporosis. This application utilizes DEXA to estimate bone density to analyze osteoporosis and evaluate the risk of fractures. As a result, the increasing prevalence of osteoporosis is anticipated to improve the adoption of DEXA in several hospitals. Moreover, numerous hospitals across the globe, such as Apollo Hospitals (India), Ramsay Health Care (UK), Jackson Hospital (US), and Elkhart General Hospital (US), have now contained body composition testing as a component of their patient care and wellness programs. Such developments are anticipated to help the growth of this end-user segment in the coming years.

How is the body composition analyzers market performing in regions?

The North American is anticipated to hold the maximum body composition analyzers market. The evolution in the region has been attributed to several factors, such as the growth in obesity rates and the investments made by different governments. The data published in May 2022 by the Center for Chronic Disease Prevention (CDC) calculated that the annual medical expense of obesity in the United States was about USD 173 billion in 2019. Medical expenses for adults with obesity were USD 1,861 higher than medical costs for people with a healthy weight. More increased consumption of fast food and a lower amount of physical activity has shown the increasing trends in obesity. This trend is additionally prevalent in urban areas and is projected to boost the demand for body fat measurement devices and analyzers in the future.

Furthermore, the Asia Pacific is the fastest-growing region in the market and will hold this trend throughout the forecast period. This is anticipated due to well-established healthcare infrastructure and ongoing R&D enterprises in growing body composition analyzers. Furthermore, the introduction & adoption of new technologies and high disposable income drive the market growth in this region.

What is the regulatory landscape for the body composition analyzers market?

The obesity-associated FTO region instantly interacts with the supporters of IRX3 and FTO in humans. Furthermore, long-range enhancers within this region abstract aspects of the IRX3 term, suggesting that the obesity-associated interval belongs to the regulatory landscape of IRX3. Uniform with this, obesity-associated single nucleotide polymorphisms are associated with the word IRX3, but not FTO, in human brains. A direct link between IRX3 presentation and regulation of body mass and arrangement is indicated by a decrease in body weight of 25 to 30% in Irx3-deficient mice, especially through the failure of fat mass and growth in basal metabolic rate with browning of white fatty tissue. Finally, the hypothalamic declaration of a dominant-negative form of Irx3 produces the metabolic phenotypes of Irx3-deficient mice.

What is the Market Size of the body composition analyzers regarding value?

The global body composition analyzersmarket is anticipated to grow at a substantial CAGR of 12.40% in the upcoming years. The global Body Composition Analyzers industry was estimated to be worth USD 642.5 million in 2021 and was expected to be worth USD 1295.6 million by 2028.

What are the major players planning for the future of the body composition analyzers market?

The key players in the body composition analyzer market are investing heavily in multiple cutting-edge technologies. Many enterprises like Zurich Instruments AG and Tanita manufacture bio-impedance analysis devices. For example, one of Tanita's flagship products, the BF679W, can be utilized to measure a patient's bio-impedance. This can then calculate muscle mass, quality, body fat percentage, and visceral fat.

Segmentation of Global Body Composition Analyzers Market-

Global Body Composition Analyzers Market – By Product

• Bio-Impedance Analyzers
• Dual-Energy X-Ray Absorptiometry (DEXA)
• SkinfoldCalipers
• Air Displacement Plethysmography (ADP)
• Hydrostatic Weighing (HWD)
•  

Global Body Composition Analyzers Market – By End Users

• Hospitals
• Fitness Centers
• Academic & Research Centers
• Home Users
•  

Global Body Composition Analyzers Market – By Region

• North America
  •  
  • Canada
• Europe
  • Germany
  • France
  • K.
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • South-east Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa